Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Pioglitazone on TIMP-3 and TACE in Type 2 Diabetes
NCT01223196Phase 4Completed
- Sponsor
- UT Health San Antonio
- Start
- Aug 2009
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pioglitazone in type 2 diabetes mellitus (T2DM), sponsored by UT Health San Antonio. Started Aug 2009; status: completed.
02
Drugs
pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01223196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01223196.